Home GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas
 

Keywords :   


GlaxoSmithKline plc's (GSK) Neutral Rating Reaffirmed at BNP Paribas

2016-01-09 20:38:11| Biotech - Topix.net

's stock had its "neutral" rating restated by analysts at BNP Paribas in a report issued on Friday, MarketBeat Ratings reports. They presently have a GBX 1,400 target price on the stock.

Tags: rating neutral bnp reaffirmed

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
More »